Abstract Purpose of Review Extracorporeal photochemotherapy (photopheresis, ECP) is a
cell-based immunomodulatory treatment that separates leukocytes from peripheral blood …

Although there have been no major breakthroughs in scleroderma therapy, new treatments
have been tested in patients with systemic sclerosis, including both interferon alfa and …

Eight patients with progressive systemic sclerosis were treated with photopheresis or
extracorporeal photochemotherapy given on 2 consecutive days every 4 weeks for 5 to 8 …

Background: Extracorporeal photochemotherapy (EXP) is an immunomodulating therapy
that has been used in a limited number of patients with systemic sclerosis (SSC) with …

Morphea, or localized scleroderma, can at times constitute a severely disabling and
aggressive disease with no single therapy proven to be curative or the standard of care …

Systemic scleroderma—also known as systemic sclerosis (SS c)—is a chronic systemic
connective tissue disease characterized by collagen deposition in cutaneous and internal …

The aim of this study was to evaluate the clinical and immunomodulatory effects of
extracorporeal photochemotherapy (ECP) in systemic sclerosis (SSc). We enrolled 16 …

Extracorporeal photophoresis (ECP), a therapeutic modality that has been under
investigation for some years, is based on separation of a leucocyte/lymphocyte-enriched cell …

Extracorporeal photopheresis (ECP or photopheresis) is an advanced therapeutic apheresis
procedure in which blood is separated into its various components and the isolated buffy …

Scleromyxedema is an uncommon disease of unclear etiology. Therapy is difficult. Two
patients with scleromyxedema were treated with extracorporeal photopheresis (ECP). The …